Skip to main content

Table 4 Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, non-Hispanic whites (95% CI in parentheses): Cancer sites with no evidence of an inverse association with solar UV-B exposure (see notes for Table 2).

From: Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002

  Incidence Mortality
Cancer site Males Females Males Females
Liver and intrahepatic bile duct 1.01 (0.95–1.08) 1.05 (0.96–1.14) 0.88 (0.85–0.92) 0.85 (0.81–0.89)
Nose, nasal cavity, and inner ear 0.80 (0.68–0.95) 0.85 (0.71–1.03) 0.93 (0.76–1.13) 0.99 (0.80–1.23)
Larynx 0.87 (0.82–0.92) 0.80 (0.72–0.89) 1.04 (0.98–1.11) 0.96 (0.86–1.07)
Bone and joint 0.83 (0.69–1.01) 0.95 (0.78–1.17) 0.62 (0.54–0.72) 0.57 (0.49–0.66)
Soft tissue, including heart 0.84 (0.77–0.92) 0.94 (0.85–1.03) 1.10 (1.02–1.19) 1.23 (1.14–1.33)
Ovary   1.03 (0.99–1.06)   1.09 (1.06–1.11)
Brain and other nervous system 1.08 (1.02–1.14) 1.07 (1.01–1.14) 0.91 (0.87–0.94) 0.86 (0.83–0.90)
Thyroid (males) 1.05 (0.96–1.13)   1.00 (0.87–1.16)  
Miscellaneous sites 0.83 (0.79–0.86) 0.93 (0.89–-0.97) 1.16 (1.13–1.18) 1.23 (1.20–1.26)